The Laboratory tubes

Product

China Supplier Cidofovir hydrate - Rivaroxaban 366789-02-8 Blood system protect Antithrombosis – Neore

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

Our mission is usually to turn into an innovative provider of high-tech digital and communication devices by providing worth added design and style, world-class producing, and repair capabilities for Tulathromycin 217500-96-4, Metronidazole Benzoate 13182-89-3, Beta Arbutin, We warmly welcome domestic and abroad buyers deliver inquiry to us ,we now have 24hours doing work team! Anytime anywhere we are still here to be your partner.
China Supplier Cidofovir hydrate - Rivaroxaban 366789-02-8 Blood system protect Antithrombosis – Neore Detail:

Payment: T/T, L/C
Product Origin: China
Shipping Port: Beijing/Shanghai/Hangzhou
Production capacity: 200kg/month
Order(MOQ): 25kg
Lead Time: 3 Working Days
Storage condition: Stored in cool, dry place, room temperature.
Package material: drum
Package size: 25kg/drum
Safety information:  Not dangerous goods

Rivaroxaban

Introduction

Rivaroxaban, is an anticoagulant medication (blood thinner). It use in adults with nonvalvular atrial fibrillation (except atrial fibrillation due to rheumatic valvular heart disease, and atrial fibrillation after heart valve replacement) to reduce the risk of stroke and systemic embolism.
Rivaroxaban, is used to treat and prevent blood clots.
Rivaroxaban, is used f for adult patients undergoing elective hip or knee replacement surgery to prevent venous thrombosis.

Specification (EP)

Item

Specification

Appearance

White or yellowish powder

Solubility

Practically insoluble in water, freely soluble in DMSO, practically insoluble in anhydrous ethanol and in heptanes.

Identification

IR: Spectrum should comply with the WS

 

HPLC-RT of sample under enantiometric purity test should comply with that of WS.

Water ≤0.5%

Sulphate ash

≤0.1%

Loss on drying

≤0.5%
Heavy metals ≤20ppm

Enantionmer

Impurity A: ≤0.4%

Residual solvent

Ethanol: ≤5000ppm

Ethyl acetate: ≤5000ppm

Acetone: ≤5000ppm

N,N-Dimethylformamide: ≤880ppm

Methylene chloride: ≤600ppm

Benzene: ≤2ppm

Related substance

Impurity B: ≤0.10%

Impurity D: ≤0.10%

Impurity E: ≤0.10%

Impurity F: ≤0.10%

Impurity G: ≤0.10%

Impurity H: ≤0.10%

Impurity I: ≤0.10%

Impurity J: ≤0.10%

RVB-4-NJSH: ≤0.10%

RVB-ZA: ≤0.10%

RVB-BAM: ≤0.10%

RVB-ZC: ≤0.10%

RVB-HBY: ≤75ppm

Any other unknown impurity: ≤0.10%

Total impurity: ≤0.3%

Particle size distribution

D10:/

D50:/

D90:/

Assay

(anhydrous substance)

98.0-102.0

Product detail pictures:

China Supplier Cidofovir hydrate - Rivaroxaban 366789-02-8 Blood system protect Antithrombosis – Neore detail pictures


Related Product Guide:

We are convinced that with joint endeavours, the small business between us will bring us mutual benefits. We could assure you products quality and competitive selling price for China Supplier Cidofovir hydrate - Rivaroxaban 366789-02-8 Blood system protect Antithrombosis – Neore , The product will supply to all over the world, such as: Latvia, French, Frankfurt, "Good quality, Good service " is always our tenet and credo. We take every effort to control the quality, package, labels etc and our QC will check every detail during producing and before shipment. We have been willing to establish long business relationship with all those who seek the high quality products and good service. We've got set up a wide sales network across European countries, North of America, South of America, Middle East, Africa, East Asia countries.Please contact us now, you will find our expert experience and high quality grades will contribute to your business.
  • The company can keep up with the changes in this industry market, product updates fast and the price is cheap, this is our second cooperation, it's good.
    5 Stars By Agustin from Buenos Aires - 2017.01.28 18:53
    After the signing of the contract, we received satisfactory goods in a short term, this is a commendable manufacturer.
    5 Stars By Maud from Cairo - 2017.06.16 18:23